
Seneca Therapeutics
Developer of cell-based therapies designed to offer therapeutics and vaccines for solid cancer. The company focuses on oncolytic immunotherapeutic candidates to synergize with immune checkpoint inhibi...
Valuation
$0
Share Price
N/A
Total Raised
$25.2M
Last Round
N/A